Method for constructing mathematical model for detecting gastric cancer in vitro and application thereof
A mathematical model and external detection technology, applied in the field of medical diagnosis, to achieve the effect of improving precision and accuracy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] Use the purchased chemiluminescence detection kit to test the concentration of 13 gastric cancer protein markers (PG I / II, CA724, CA199, G-17, CEA, CCDC49, RNF19, BFAR, COPS2, CTSF, NT5E, TERF1) in blood samples , using fluorescent in situ hybridization or sequencing to test the concentrations of 14 gastric cancer molecular markers (C-erbB-2, ETFR, nm23, E-Cad, BCL6B, HER-2, Ki-67, CD133, cyclinB1, LRP16 , NF-κB, CgA, CD56, TMEFF2), the concentrations of 14 gastric cancer-related DNA methylation markers (Sox17, Runx3, WNT5A, MLH1, CDH1, RUNX3, CD44, hMLH1, CDKN1C , IGFBP3, PRDM5, MINT25, DAPK, GSTP1).
[0034] Perform logistic regression analysis on the test concentrations of the above-mentioned relevant markers to obtain Logit(P)=constant+λ1*P1+λ2*P2+η3*P3+η4*P4...
[0035] Then test the concentration of each marker in the unknown blood sample and substitute it into the regression model. According to the calculated Logit (P) and the judgment standard of the regression...
Embodiment 2
[0038] The concentration of 10 gastric cancer protein markers (PG I / II, CA724, G-17, CCDC49, RNF19, BFAR, COPS2, CTSF, NT5E, TERF1) in blood samples was tested with a purchased or self-made chemiluminescent method kit. Nine gastric cancer molecular markers (miR-199a-3p, miR-195, miR-106b, miR-129, miR125b, miR199a, miR433, miR-223, miR-218) in blood samples were tested by fluorescence in situ hybridization. The concentration of 7 kinds of gastric cancer autoantibodies (NY-ESO-1, CTAG2, DDX53, MAGEC1, MAGEA3, AEG-1, GRP78) in blood samples was detected by immunofluorescence method, and 8 kinds of gastric cancer were detected in urine or blood by flow cytometry fluorescence method Related exosomes (miR-221, TGF-β1, HMGB1, CagA, GKN1, UBR2, TRIM3, miR-130a), 12 gastric cancer-related DNA methylation markers in urine or blood were detected by flow cytometry ( WNT5A, RUNX3, MINT25, RORA, GDNF, ADAM23, PRDM5, hMLH1, IGFBP3, PRDM5, DAPK, GSTP1)
[0039] Perform logistic regression a...
Embodiment 3
[0043] Using purchased or self-made chemiluminescence kits, test gastric cancer protein markers as PG I / II, CA724, CA242, CA50, G-17, CCDC49, RNF19, BFAR, COPS2, CTSF, gastric cancer molecular diagnostic markers as p53 , C-erbB-2, ETFR, nm23, E-Cad, BCL6B, HER-2, Ki-67, CD133, EGFR, gastric cancer-related DNA methylation markers are Sox17, WNT5A, MLH1, p16, CDH1, RUNX3, MINT25, obtain the concentration values of these markers in the sample, carry out natural logarithmic transformation, after logistic regression analysis, after removing the markers without contribution, the regression model obtained is: Logit(P)=-3.736+1.814*Ln(PG I / II)+0.854*Ln(CA724)+0.754*Ln(CA242)+0.321*Ln(G-17)+0.784*Ln(BFAR)+1.014*Ln(COPS2)+0.741*Ln(p53)+0.654* Ln(nm23)+0.789*Ln(HER-2)+0.654*Ln(Ki-67)+0.714*Ln(Sox17)+0.324*Ln(MLH1)+0.874*Ln(RUNX3), where Ln is natural logarithm .
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com